Skip to main content

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.

About The Oncology Institute, Inc.

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.16
+4.82 (2.06%)
AAPL  248.04
-0.31 (-0.12%)
AMD  259.68
+5.95 (2.35%)
BAC  51.72
-0.73 (-1.39%)
GOOG  328.43
-2.41 (-0.73%)
META  658.76
+11.13 (1.72%)
MSFT  465.95
+14.81 (3.28%)
NVDA  187.67
+2.83 (1.53%)
ORCL  177.16
-1.02 (-0.57%)
TSLA  449.06
-0.30 (-0.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.